American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

The Brief: January 2, 2020

With 2019 at an end, ACS would like to wish its members, partners and other industry professionals a happy New Year. As we reflect on the past year for the industry, we would like to provide the readers of The Brief a look at the 20 most accessed articles from the year. Here is Part 2, 11-20. Our regular publication will resume Thursday, Jan. 9.

No accreditation fee increases planned for 2020

From Aug. 8: There will be no fee increases in 2020 for any of the accreditation program categories of the Commission on Cancer (CoC), the National Accreditation Program for Breast Centers (NAPBC), or the National Accreditation Program for Rectal Cancer (NAPRC).

The 2020 category-based fee schedules for both CoC- and NAPRC-accredited programs are available on the CoC Datalinks Activity Menu under Resources. For CoC-accredited programs, cancer program administrators, cancer committee chairs, cancer liaison physicians and certified tumor registrars can download the schedule; other Datalinks users who require this information should contact staff in these roles at their facilities. For NAPRC-accredited programs, the 2020 fee schedule in CoC Datalinks can be downloaded by staff contacts designated by the facility.

Join the CoC and NAPBC surveyor teams

From July 25: The CoC and the National Accreditation Program for Breast Centers (NAPBC) are actively seeking medical professionals to join their accreditation survey teams. Physicians with an interest in learning more about patient care around the country, as well as a desire to positively impact the quality of that care, are strongly encouraged to apply.

Accreditation by the CoC and NAPBC, quality programs of the American College of Surgeons, demonstrates a cancer program's commitment to providing high-quality, multidisciplinary, patient-centered cancer care. Surveyors perform a vital service in the accreditation process through site visits to and evaluation of cancer programs.

More information is available in the CoC and NAPBC surveyor applications.

Patients and caregivers withhold cancer-related information

Oncology Nursing News

From May 2: Patients with gynecologic cancer and their caregivers may claim that they tell their healthcare providers everything, but there are still some issues that go undiscussed, according to recent research conducted across multiple institutions and published in the Oncology Nursing Forum. Researchers conducted semi-structured phone interviews with 18 patients in treatment for their first appearance of ovarian, uterine, or endometrial cancer who were between treatment cycles 2 and 5, as well as 16 supporters (89% of participants were patient-supporter dyads). READ MORE

Scholarship recipients to attend ACS 2019 Quality and Safety Conference

From July 18: A group of 25 cancer registrars from accredited institutions has been awarded scholarships to attend the American College of Surgeons (ACS) 2019 Quality and Safety Conference this week in Washington, DC. ACS Cancer Programs awarded each of the registrars a $1,000 scholarship to help cover registration, travel and hotel costs. Those attending will have the opportunity to attend educational sessions, meet Cancer Program members and staff and network with colleagues from around the country.

CoC announces 2018 Outstanding Achievement Award (OAA) Recipients

From March 7: The Commission on Cancer (CoC), a quality program of the American College of Surgeons recognizes the 24 recipients of the 2018 Outstanding Achievement Award (OAA). The OAA designation is presented to exceptional CoC-accredited programs that have met the criteria for all seven commendation-eligible CoC Standards as well as achieving compliance with the remaining 27 standards that are required for accreditation. "These cancer programs currently represent the highest quality of cancer care," stated Larry N. Shulman, MD, FACP, and Chair of the CoC. "Each of these facilities has committed itself to continuous quality assessment and improvement, and has proved that this approach yields the high quality cancer care that all of our patients should expect," he added. Additional information about the OAA and the 2018 recipients can be found online.

How to starve triple negative breast cancer

American Society for Biochemistry and Molecular Biology via ScienceDaily

From May 16: A team of Brazilian researchers has developed a strategy that slows the growth of triple negative breast cancer cells by cutting them off from two major food sources. Triple-negative breast cancer, or TNBC, makes up approximately 15% to 20% of all breast cancers and is most common in African American women. These tumors lack estrogen and progesterone receptors and HER2 protein which are present in other breast cancers and permit certain targeted therapies. READ MORE

Cancer and nutrition research: How best to move it forward

Medical News Today

From Aug. 8: In the past few decades, a number of studies have suggested a link between dietary habits and the development of cancer. However, much of this research has been unable to move beyond observing links. Now, specialists in cancer and nutrition suggest a way forward. READ MORE

The ACS and Cancer Programs recognized David P. Winchester

American College of Surgeons

From Feb. 14: Dr. David P. Winchester and Marilyn WinchesterThe American College of Surgeons (ACS) and the Cancer Programs recognized David P. Winchester, MD, FACS, on his official retirement after more than 30 years of contributions as Medical Director. Dr. Winchester served under five ACS Executive Directors and worked tirelessly as a surgical oncologist and as Medical Director of Cancer Programs to improve the quality of care of the cancer patient. His contributions through the American Joint Committee on Cancer and Commission on Cancer are immeasurable. He established the National Cancer Database in concert with the American Cancer Society, created the Clinical Research Program in collaboration with the Alliance and fostered the development of the National Accreditation Program for Breast Centers and the newest National Accreditation Program for Rectal Cancer. Dr. Winchester's career and contributions were celebrated by the Cancer Programs leaders in January, and the ACS staff and Board of Regents this past week. We are indebted to him for his contributions and impact on cancer patient care.

Drug to replace chemotherapy may reshape cancer care


From June 13: A class of drugs is emerging that can attack cancer cells in the body without damaging surrounding healthy ones. They have the potential to replace chemotherapy and its disruptive side effects, reshaping the future of cancer care. The complex biological medicines, called antibody drug conjugates (ADCs), have been in development for decades, and are now generating renewed excitement because of the success of one ADC in late-stage testing, a breast cancer treatment called DS-8201. READ MORE

Skin cancer rates rocket by 45% in 10 years

Cancer Research UK

From July 25: Melanoma skin cancer incidence rates have soared by 45% since 2004 according to the latest figures released by Cancer Research UK. Rates have increased by more than a third (35%) for women and by almost three-fifths (55%) for men. Cancer risk generally goes up with age and, while melanoma is still more common in those over 65, rates for 25-49 year-olds have increased by 70% since the 1990s. READ MORE